Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Featured Services
A to Z Drug List
Drugs by Condition
Pill Identifier
Drug Side Effects
Drug Dosage
Interactions Checker
News & Articles
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Drug Imprint Codes
International Drugs
Drugs by Category
Pregnancy Warnings
Inactive Ingredients
Video Center
 Medical Conferences
Health Guides
Symptom Checker
FDA Consumer Updates Medication Record
Clinical Trial Results
Medical Encyclopedia
Medical Dictionary
Patient Care Notes
For Professionals
Generic Drugs
Veterinary Drugs
Popular Articles
Pill Identifier App (itunes)
Pill Reminder App (itunes)
Info en Español
Top 100 Drugs
Top 200 by sales
Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon
 Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone
 Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec
More A-K · More L-Z · By Class · UK Medicines
For Consumers For Professionals For Researchers Announcements
Latest FDA New Drug Approvals

Fabior
Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.

Dymista
Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of ...

Elelyso
Elelyso (taliglucerase alfa) is a plant-cell expressed recombinant form of glucocerebrosidase for the treatment of Gaucher disease.

More...

Drugs in Development – Not yet approved

cobicistat, elvitegravir, emtricitabine and tenofovir
The Quad (cobicistat, elvitegravir, emtricitabine and tenofovir) is a once-daily, single-tablet combination containing an integrase ...

Lorqess
Lorqess (lorcaserin) is a selective serotonin 2C receptor agonist in development for weight management, including weight loss and ...

tofacitinib
Tofacitinib is an investigational, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active ...

More...

Daily Medical News

RSS
Genes Might Be Key to Parkinson's Spread
TUESDAY, May 15 -- Researchers have identified gene variants that speed the progression of Parkinson's disease, and they say their findings could help identify patients who would benefit most from early treatment. The researchers, from the University of California-Los Angeles, say their findings also may help efforts to develop new therapies. Parkinson's disease is a progressive movement...
Asthma Cases Continue to Rise in U.S., Affecting Millions
TUESDAY, May 15 -- Asthma continues to take its toll on Americans, with almost 19 million adults (8.2 percent) suffering from the disorder in 2010, according to a report released Tuesday by the U.S. Centers for Disease Control and Prevention. The CDC analysis also found that more than 29 million (almost 13 percent) of adults have been diagnosed with the illness at some point in their...
Trial Set to See if Drug Can Prevent Alzheimer's
TUESDAY, May 15 -- Researchers are preparing to test an experimental drug in people genetically primed to develop Alzheimer's disease. The best-scenario hope is that the drug will lead to a way of preventing the progressive brain-wasting disease, and to a better understanding of its destructive processes, U.S. officials announced Tuesday. The study volunteers will include some Americans as well...

More...

Latest Pharma Industry News

RSS
Stiefel Receives US FDA Approval of Fabior Foam, 0.1%
RESEARCH TRIANGLE PARK, N.C., May 11, 2012 /PRNewswire/ -- Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam, 0.1%. It is the only retinoid in a topical foam formulation for the treatment of acne vulgaris in patients 12 years of age and older. "Stiefel is dedicated to meeting the needs of...
Groundbreaking Alzheimer's Disease Prevention Trial Announced
Study of Novel Anti-Amyloid Therapy Will Help Launch New Research Era   PHOENIX, May 15, 2012 /PRNewswire/ -- In collaboration with the National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announce the first-ever prevention trial in cognitively healthy individuals...
FDA Drug Safety Communication: Revised Recommendations for Cardiovascular Monitoring and Use of Multiple Sclerosis Drug Gilenya (Fingolimod)
This update is in follow-up to the FDA Drug Safety Communication: Safety review of a reported death after the first dose of multiple sclerosis drug Gilenya (fingolimod) 1on 12/20/2011. Safety Announcement The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya (fingolimod). The agency...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Fabior, Elelyso, Dymista, Stendra, Amyvid, Binosto, QNASL, Omontys, Surfaxin, Viokace ...also see new filings.
Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch
Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...
Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store
We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more information on our growing ...
Pill Identifier Update
We have updated the pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest ...
See more blog posts or follow us on twitter.

(web5)